Page last updated: 2024-09-03

nifekalant hydrochloride and pilsicainide

nifekalant hydrochloride has been researched along with pilsicainide in 3 studies

Compound Research Comparison

Studies
(nifekalant hydrochloride)
Trials
(nifekalant hydrochloride)
Recent Studies (post-2010)
(nifekalant hydrochloride)
Studies
(pilsicainide)
Trials
(pilsicainide)
Recent Studies (post-2010) (pilsicainide)
13816382152543

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiki, A; Hayashi, H; Inoue, H; Tani, M; Usui, M1
Arakaki, T; Isomoto, S; Kawakami, A; Ono, K; Yamashita, S; Yano, K1
Hirayama, A; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I1

Other Studies

3 other study(ies) available for nifekalant hydrochloride and pilsicainide

ArticleYear
Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Dogs; Electric Stimulation; Female; Lidocaine; Male; Pyrimidinones; Vagus Nerve

1998
Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells.
    Journal of pharmacological sciences, 2006, Volume: 101, Issue:4

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Apoptosis; Caspases; Cell Line; Clone Cells; Diploidy; DNA Fragmentation; Dose-Response Relationship, Drug; Lidocaine; Membrane Potentials; Mitochondrial Membranes; Propranolol; Pyrimidinones; Signal Transduction; Time Factors; Verapamil

2006
Pharmacologic atrial defibrillation by drug delivery into the temporarily occluded coronary sinus. A canine study.
    International heart journal, 2012, Volume: 53, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Balloon Occlusion; Cardiac Pacing, Artificial; Chronic Disease; Coronary Sinus; Dogs; Drug Delivery Systems; Injections, Intravenous; Lidocaine; Pyrimidinones; Treatment Outcome

2012